image
Syndax Pharmaceuticals, Inc. SNDX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 15.83
-5.72 %
$ 1.35 B
Market Cap
-4.31
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-230 M OPERATING INCOME
-51.53%
Growth Rates
1Year -51.53%
3Years -47.66%
5Years -24.83%
7Years -26.74%
10Years -38.95%
-209 M NET INCOME
-40.19%
Growth Rates
1Year -40.19%
3Years -41.97%
5Years -23.13%
7Years -24.77%
10Years -30.90%
EFFICIENCY
Earnings Waterfall Syndax Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 12 K
Gross Profit -12 K
Operating Expenses 230 M
Operating Income -230 M
Other Expenses -20.6 M
Net Income -209 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 139.7 1.5 1.5 1.5 2.1 1.2 0.6 0 0 0
GROSS PROFIT
Cost Of Revenue 12 K 0.5 0.5 0 0 0 0 0 0 0 0 0
Gross Profit 12 K (0.5) 139.3 1.5 1.5 1.5 2.1 1.2 0.6 0 0 0
OPERATING INCOME
Operating Expenses 230.0 151.8 113.5 72.9 59.1 77.4 64.1 45.0 21.1 21.3 8.6 8.7
Selling, General and Administrative Expenses 66.9 33.3 25.2 22.5 16.1 17.3 15.9 13.3 11.6 11.2 5.4 3.5
Research and Development Expenses 163.0 118.5 88.2 50.4 43.0 60.1 48.2 31.7 9.5 10.2 3.2 5.2
Operating Income (230.0) (151.8) 26.2 (71.4) (57.5) (75.9) (62.0) (43.8) (20.5) (21.3) (8.6) (8.7)
PRE-TAX INCOME
Interest Income Expense 0.2 3.1 1.9 2.4 1.6 1.9 1.4 1.0 1.6 0 0 0
Total Other Income 20.6 2.4 (1.3) (1.7) 1.5 1.9 1.2 (0.7) (3.6) 1.5 (5.6) (1.2)
Pre-Tax Income (209.4) (149.3) 24.9 (73.2) (56.0) (74.0) (60.8) (44.5) (24.1) (19.8) (14.2) (10.0)
NET INCOME
Tax Provision 0 (5.6) 43 K 89 K 92 K 1.9 76 K 89 K 1.5 (1.5) 2.6 1.2
Net Income (209.4) (143.7) 24.9 (73.1) (56.0) (74.0) (60.8) (44.5) (24.1) (19.8) (14.2) (10.0)
EPS 2.98 2.37 0.48 1.77 1.84 2.92 2.9 3.04 1.39 2.07 1.77 0.14